Entrada Therapeutics, Inc. · NASDAQ:TRDA
Roche Finance Ltd reported a 6.90% stake in Entrada Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Roche Finance Ltd reported a 6.90% stake in Entrada Therapeutics, Inc., 2,569,115 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.90%
- Shares
- 2,569,115
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Roche Finance Ltd | 6.90% | 2,569,115 |
| Roche Holding Ltd | 6.90% | 2,569,115 |
Source
Related
- Entrada Therapeutics, Inc.
- Roche Finance Ltd
- Entrada Therapeutics, Inc. shareholders
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026